At risk for schizophrenic or affective psychoses? A meta-analysis of DSM/ICD diagnostic outcomes in individuals at high clinical risk

Schizophrenia Bulletin

Volumn 39, Issue 4, 2013, Pages 923-932

  Fusar Poli, Paolo ^a   Bechdolf, Andreas ^b   Taylor, Matthew John ^a   Bonoldi, Ilaria ^a   Carpenter, William T ^c,d   Yung, Alison Ruth ^b   McGuire, Philip ^a  

^a SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d Maryland Exercise and Robotics Center of Excellence   (United States)

Author keywords

affective psychosis; ARMS; bipolar; BS; high risk; prodromal; psychosis; schizophrenia; SIPS

Indexed keywords

AFFECTIVE PSYCHOSIS; ARTICLE; BIPOLAR DISORDER; CLINICAL ASSESSMENT; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE COURSE; FOLLOW UP; HIGH RISK STATE FOR PSYCHOSIS; HUMAN; INFORMATION RETRIEVAL; INTERNATIONAL CLASSIFICATION OF DISEASES; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PUBLISHING; RISK ASSESSMENT; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SYSTEMATIC REVIEW;

EID: 84878646038     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbs060     Document Type: Article

References (64)

1. McGorry PD, Nelson B, Amminger GP, et al. Intervention in individuals at ultra-high risk for psychosis: a review and future directions. J Clin Psychiatry. 2009; 70: 1206-1212.
2. Ruhrmann S, Schultze-Lutter F, Bechdolf A, Klosterkotter J. Intervention in at-risk states for developing psychosis. Eur Arch Psychiatry Clin Neurosci. 2010; 260(suppl 2): S90-S94.
3. CarpenterWT, van Os J. Should attenuated psychosis syndrome be a DSM-5 diagnosis? Am J Psychiatry. 2011; 168: 460-463.
4. Nelson B, Yung AR. Should a risk syndrome for first episode psychosis be included in the DSM-V? Curr Opin Psychiatry. 2011; 24: 128-133.
5. Fusar-Poli P, Yung A. Should attenuated psychosis syndrome be included in the DSM5? The debate. Lancet. 2012; 379: 591-592.
6. Fusar-Poli P, Bonoldi I, Yung AR, et al. Predicting psychosis: a meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry. 2012; 69: 220-229.
7. Yung AR, Nelson B, Stanford C, et al. Validation of "prodromal" criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up. Schizophr Res. 2008; 105: 10-17.
8. Fusar-Poli P, Deste G, Smieskova R, et al. Cognitive functioning in prodromal psychosis: a meta-analysis. Arch Gen Psychiatry. 2012; In press.
9. Fusar-Poli P, Borgwardt S, Crescini A, et al. Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis. Neurosci Biobehav Rev. 2011; 35: 1175-1185.
10. Fusar-Poli P, Radua J, McGuire P, Borgwardt S. Neuroanatomical maps of psychosis onset: voxel-wise meta-analysis of antipsychotic-naive VBM studies. [published online ahead of print November 10, 2011]. Schizophr Bull. 2011. doi: 10.1093/schbul/sbr134.
11. Smieskova R, Fusar-Poli P, Allen P, et al. Neuroimaging predictors of transition to psychosis-A systematic review and meta-analysis. Neurosci Biobehav Rev. 2010; 34: 1207-1222.
12. Fusar-Poli P, Perez J, Broome M, et al. Neurofunctional correlates of vulnerability to psychosis: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2007; 31: 465-484. (Pubitemid 46527879)
13. Altamura AC, Goikolea JM. Differential diagnoses and management strategies in patients with schizophrenia and bipolar disorder. Neuropsychiatr Dis Treat. 2008; 4: 311-317. (Pubitemid 351460971)
14. McNamara RK, Nandagopal JJ, Strakowski SM, DelBello MP. Preventative strategies for early-onset bipolar disorder: towards a clinical staging model. CNS Drugs. 2010; 24: 983-996.
15. Bechdolf A, Nelson B, Cotton SM, et al. A preliminary evaluation of the validity of at-risk criteria for bipolar disorders in help-seeking adolescents and young adults. J Affect Disord. 2010; 127: 316-320.
16. Iacoviello BM, Alloy LB, Abramson LY, Choi JY. The early course of depression: a longitudinal investigation of prodromal symptoms and their relation to the symptomatic course of depressive episodes. J Abnorm Psychol. 2010; 119: 459-467.
17. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009; 339: b2535.
18. Paulson JF, Bazemore SD. Prenatal and postpartum depression in fathers and its association with maternal depression: a meta-analysis. JAMA. 2010; 303: 1961-1969.
19. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000; 283: 2008-2012. (Pubitemid 30214957)
20. Borenstein MHL, Higgins J, Rothstein H. Comprehensive Meta-Analysis Version 2. Englewood, NJ: Biostat; 2005.
21. Nielssen O, Large M. Rates of homicide during the first episode of psychosis and after treatment: a systematic review and meta-analysis. Schizophr Bull. 2010; 36: 702-712.
22. Lipsey M, Wilson D. Practical Meta-Analysis. Thousand Oaks, CA: Sage Publications; 2000.
23. EggerM, Davey Smith G, SchneiderM, Minder C. Bias in metaanalysis detected by a simple, graphical test. BMJ. 1997; 315: 629-634. (Pubitemid 27387172)
24. Orwin R. A fail-safe N for effect size in meta-analysis. J Educ Stat. 1983; 8: 157-159.
25. Van Os J, Linscott R, Myin-Germeys I, Delespaul P, Krabbendam L. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness- persistence-impairment model of psychotic disorder. Psychol Med. 2009; 39: 179-195.
26. Klosterkotter J, Hellmich M, Steinmeyer EM, Schultze- Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry. 2001; 58: 158-164. (Pubitemid 32142753)
27. Miller TJ, McGlashan TH, Rosen JL, et al. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull. 2003; 29: 703-715. (Pubitemid 38181951)
28. Yung AR, Phillips LJ, Yuen HP, McGorry PD. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr Res. 2004; 67: 131-142. (Pubitemid 38251443)
29. Mason O, Startup M, Halpin S, Schall U, Conrad A, Carr V. Risk factors for transition to first episode psychosis among individuals with "at-risk mental states". Schizophr Res. 2004; 71: 227-237. (Pubitemid 39330501)
30. Lencz T, Smith CW, McLaughlin D. Generalized and specific neurocognitive deficits in prodromal schizophrenia. Biol Psychiatry. 2006; 59: 863-871.
31. Schultze-Lutter F, Klosterkotter J, Picker H, Steinmeyer E, Ruhrmann S. Predictin first-episode psychosis by basic symptoms criteria. Clin Neuropsychiatry. 2007; 4: 11-22. (Pubitemid 47072411)
32. Phillips LJ, McGorry PD, Yuen HP.Medium term follow-up of a randomized controlled trial of interventions for young people at ultra high risk of psychosis. Schizophr Res. 2007; 96: 25-33. (Pubitemid 47494628)
33. Cornblatt BA, Lencz T, Smith CW. Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents. J Clin Psychiatry. 2007; 68: 546-557. (Pubitemid 46663037)
34. Borgwardt SJ, McGuire PK, Aston J. Reductions in frontal, temporal and parietal volume associated with the onset of psychosis. Schizophr Res. 2008; 106: 108-114.
35. Koutsouleris N, Schmitt GJ, Gaser C. Neuroanatomical correlates of different vulnerability states for psychosis and their clinical outcomes. Br J Psychiatry. 2009; 195: 218-226.
36. Woods SW, Addington J, Cadenhead KS. Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr Bull. 2009; 35: 894-908.
37. Keri S, Kiss I, Kelemen O. Effects of a neuregulin 1 variant on conversion to schizophrenia and schizophreniform disorder in people at high risk for psychosis. Mol Psychiatry. 2009; 14: 118-119.
38. Lemos-Giraldez S, Vallina-Fernandez O, Fernandez-Iglesias P. Symptomatic and functional outcome in youth at ultra-high risk for psychosis: a longitudinal study. Schizophr Res. 2009; 115: 121-129.
39. Ruhrmann S, Schultze-Lutter F, Salokangas RK. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry. 2010; 67: 241-251.
40. Nelson B, Yung AR. Can clinicians predict psychosis in an ultra high risk group? Aust N Z J Psychiatry. 2010; 44: 625-630.
41. Sabb FW, van Erp TG, Hardt ME. Language network dysfunction as a predictor of outcome in youth at clinical high risk for psychosis. Schizophr Res. 2010; 116: 173-183.
42. Velthorst E, Nieman DH, Klaassen RM. Three-year course of clinical symptomatology in young people at ultra high risk for transition to psychosis. Acta Psychiatr Scand. 2010; 123: 36-42.
43. Mittal VA, Walker EF, Bearden CE. Markers of basal ganglia dysfunction and conversion to psychosis: neurocognitive deficits and dyskinesias in the prodromal period. Biol Psychiatry. 2010; 68: 93-99.
44. Simon AE, Umbricht D. High remission rates from an initial ultra-high risk state for psychosis. Schizophr Res. 2010; 116: 168-172.
45. Demjaha A, Valmaggia L, Stahl D, Byrne M, McGuire P. Disorganization/ cognitive and negative symptom dimensions in the at-risk mental state predict subsequent transition to psychosis. Schizophr Bull. 2012; 38: 351-359.
46. Bechdolf A, Thompson A, Nelson B. Experience of trauma and conversion to psychosis in an ultra-high-risk (prodromal) group. Acta Psychiatr Scand. 2010; 121: 377-384.
47. Amminger GP, Schafer MR, Papageorgiou K. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry. 2010; 67: 146-154.
48. Ziermans T, Schothorst P, Sprong M, Van Engeland E. Transition and remission in adolescents at ultra-high risk for psychosis. Schizophr Res. 2011; 126: 58-64.
49. Cannon TD, Cadenhead K, Cornblatt B. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry. 2008; 65: 28-37.
50. Perala J, Suvisaari J, Saarni SI, et al. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry. 2007; 64: 19-28. (Pubitemid 46041735)
51. Fusar-Poli P, Borgwardt S, Bechdolf A, et al. The psychosis high risk state: a comprehensive state of the art review. Arch Gen Psychiatry. 2012; In press.
52. Fusar-Poli P, Borgwardt S. Integrating the negative psychotic symptoms in the high risk criteria for the prediction of psychosis. Med Hypotheses. 2007; 69: 959-960. (Pubitemid 47248099)
53. Yung AR, Nelson B, Thompson A, Wood SJ. The psychosis threshold in ultra high risk (prodromal) research: is it valid? Schizophr Res. 2010; 120: 1-6.
54. Yu K, Cheung C, Leung M, Li Q, Chua S, McAlonan G. Are bipolar disorder and schizophrenia neuroanatomically distinct? An anatomical likelihood meta-analysis. Front Hum Neurosci. 2010; 4: 189.
55. Kendler KS, McGuire M, Gruenberg AM, O'Hare A, Spellman M, Walsh D. The Roscommon Family Study. IV. Affective illness, anxiety disorders, and alcoholism in relatives. Arch Gen Psychiatry. 1993; 50: 952-960. (Pubitemid 23361475)
56. Hafner H, Maurer K, Loffler W, et al. The ABC Schizophrenia Study: a preliminary overview of the results. Soc Psychiatry Psychiatr Epidemiol. 1998; 33: 380-386. (Pubitemid 28377066)
57. Green CE, McGuire PK, Ashworth M, Valmaggia LR. Outreach and Support in South London (OASIS). Outcomes of non-attenders to a service for people at high risk of psychosis: the case for a more assertive approach to assessment. Psychol Med. 2011; 41: 243-250.
58. IEPA IEPAWG.International clinical practice guidelines for early psychosis. Br J Psychiatry. 2005; 18(suppl): S120-S124.
59. Rossler W, Hengartner MP, Ajdacic-Gross V, Haker H, Gamma A, Angst J. Sub-clinical psychosis symptoms in young adults are risk factors for subsequent common mental disorders. Schizophr Res. 2011; 131: 18-23.
60. Correll CU, Penzner JB, Frederickson AM, et al. Differentiation in the preonset phases of schizophrenia and mood disorders: evidence in support of a bipolar mania prodrome. Schizophr Bull. 2007; 33: 703-714. (Pubitemid 47343729)
61. Bechdolf A, Ratheesh A, Wood S, et al. Rationale and first results of developing at-risk (prodromal) criteria for bipolar disorder. Curr Pharm Des. 2012; 18: 358-375.
62. Fusar-Poli P, Valmaggia L, McGuire P. Can antidepressants prevent psychosis? Lancet. 2007; 370: 1746-1748. (Pubitemid 350137483)
63. Berger G, Wood S, Ross M, et al. Neuroprotective effects of low-dose lithium in individuals at ultra-high risk for psychosis. A longitudinal MRI/MRS study. Curr Pharm Des. 2012; 18: 570-575.
64. McGlashan TH, Addington J, Cannon T, et al. Recruitment and treatment practices for help-seeking "prodromal" patients. Schizophr Bull. 2007; 33: 715-726. (Pubitemid 47343726)